Inhibitory effect of penciclovir-triphosphate on duck hepatitis B virus reverse transcription

Antiviral Chemistry and Chemotherapy

Volumn 8, Issue 1, 1997, Pages 38-46

  Dannaoui, E ^a   Trepo C ^a   Zoulim, F ^a  

^a INSERM   (France)

Author keywords

Hepatitis B virus; Nucleoside analogues; Reverse transcriptase

Indexed keywords

2',3' DIDEOXYGUANOSINE TRIPHOSPHATE; ACICLOVIR TRIPHOSPHATE; ANTIVIRUS AGENT; CARBOCYCLIC 2' DEOXYGUANOSINE TRIPHOSPHATE; DRUG METABOLITE; FAMCICLOVIR; GUANOSINE DERIVATIVE; PENCICLOVIR TRIPHOSPHATE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA STRAND; DNA SYNTHESIS; DRUG MECHANISM; DUCK; ENANTIOMER; HEPATITIS B VIRUS; NONHUMAN; PRIORITY JOURNAL; RABBIT; RETICULOCYTE; REVERSE TRANSCRIPTION; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 1842293414     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029700800104     Document Type: Article

References (38)

1. Aguesse S, Dannaoui E, Wang Z, Boulay A, Borel C, Schinazi R, Cheng Y, Trépo C & Zoulim F (1996) An in vitro assay for the determination of the mechanism of inhibition of hepatitis B virus replication by nucleoside analogues and non nucleoside inhibitors. Proceedings of the IX triennal international symposium of viral hepatitis and liver disease (in press).
2. Arts E & Wainberg M (1996) Mechanisms of nucleoside analogue antiviral activity and resistance during human immunodeficiency virus reverse transcription. Antimicrobial Agents and Chemotherapy 40:527-540.
3. Boyd M, Bacon T, Sutton D & Cole M (1987) Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture. Antimicrobial Agents and Chemotherapy 31:1238-1242.
4. Boyd M, Safrin S & Kern E (1993) Penciclovir: a review of its spectrum of activity, selectivity, and cross-resistance pattern. Antiviral Chemistry & Chemotherapy 4:3-11.
5. Dienstag J, Perillo R, Schiff E, Bartholomew M, Vicary C & Rubin M (1995) A preliminary trial of lamivudine for chronic hepatitis B infection. New England Journal of Medicine 333:1657-1661.
6. Earnshaw D, Bacon T, Darlison S, Edmonds K, Perkins R & Vere Hodge R (1992) Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and Varicella-Zoster virus. Antimicrobial Agents and Chemotherapy 36:2747-2757.
7. Fourel I, Cullen J, Saputelli J, Aldrich C, Schaffer P, Averett D, Pugh J & Mason W (1994a) Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks. Journal of Virology 68:8321-8330.
8. Fourel I, Saputelli J, Schaffer P & Mason W (1994b) The carbocyclic analog of 2′-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver. Journal of Virology 68:1059-1065.
9. Hafkemeyer P, Keppler-Hafkemeyer A, Haya M, von Janta-Lipinski M, Matthes E, Lehmann C, Offensperger W, Offensperger S, Gerok W & Blum H (1996) Inhibition of duck hepatitis B virus replication by 2′,3′-dideoxy-3′-fluoroguanosine in vitro and in vivo. Antimicrobial Agents and Chemotherapy 40:792-794.
10. Howe A, Robins M, Wilson J & Tyrell D (1996) Selective inhibition of the reverse transcription of duck hepatitis B virus by binding of 2′,3′-dideoxyguanosine 5′-triphosphate to the viral polymerase. Hepatology 23:87-96.
11. Korba B & Boyd M (1996) Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells. Antimicrobial Agents and Chemotherapy 40:1282-1284.
12. Krüger M, Tillmann H, Trautwein C, Bode U, Oldhafer K, Maschek H, Boker K, Broeschl C, Pichlmayr R & Manns M (1996) Famciclovir treatment of hepatitis B virus recurrence after liver transplantation. A pilot study. Liver Transplantation and Surgery 2:253-262.
13. Lanford R, Notvall L & Beames B (1995) Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells. Journal of Virology 69:4431-4439.
14. Lesnikowski Z, Juodawlkis A, Lloyd R & Schinazi R (1994) Stereoselective synthesis of (S)-and (R)-penciclovir triphosphate and their activity against viral enzymes. Antiviral Research 26:A304.
15. Lin E, Luscombe C, Wang Y, Shaw T & Locarnini S (1996) The guanine nucleoside analogue penciclovir is active against chronic duck hepatitis B virus infection in vivo. Antimicrobial Agents and Chemotherapy 40:413-418.
16. Main J, Brown J, Howells C, Galassini R, Crossey M, Karayiannis P, Georgiou P, Atkinson G & Thomas H (1996) A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection. Journal of Viral Hepatitis 3:211-215.
17. Marcellin P, Ouzan D, Degos F, Bréchot C, Metman E, Degott C, Chevallier M, Berthelot P, Trépo C & Benhamou J-P (1989) Randomized controlled trial of adenine arabinoside 5′-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients. Hepatology 10:328-331.
18. Parker W, White E, Shaddix S, Ross L, Shannon W & Secrist J (1992) Interference with HIV-1 reverse transcriptase-catalyzed DNA chain elongation by the 5′-triphosphate of the carbocyclic analogue of 2′-deoxyguanosine. Antiviral Research 19:325-332.
19. Perillo R, Schiff E, Davis G, Bodenheimer HC, Lindsay K, Payne J, Dienstag JL, O'Brien C,Tamburro C, Jacobson IM, Sampliner R, Feit D, Lefkowitch J, Kuhns M, Meschievitz C, Sanghvi B, Albrecht J & Gibas A (1990) A randomized, controlled trial of interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. New England Journal of Medicine 323:295-301.
20. Price PM, Banerjee R & Acs G (1989) Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2′-deoxyguanosine. Proceedings of the National Academy of Sciences, USA 86:8543-8544.
21. Robinson WS, Klote L & Aoki N (1990) Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma. Journal of Medical Virology 31:18-32.
22. Saltzman R, Jarewicz R & Boon R (1994) Safety of famciclovir in patients with herpes zoster and genital herpes. Antimicrobial Agents and Chemotherapy 38:2454-2457.
23. Schalm S, Heytink R, Van Buuren H & De Man R (1985) Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B. Lancet ii:358-360.
24. Seeger C, Summers J & Mason WS (1991) Viral DNA synthesis. Current Topics in Microbiology and Immunology 168:41-59.
25. Shaw T, Amor P, Civitico G, Boyd M & Locarnini S (1994) In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus. Antimicrobial Agents and Chemotherapy 38:719-723.
26. Sommadossi J-P (1994) Treatment of hepatitis B by nucleoside analogues: still a reality. Current Opinion in Infectious Diseases 7:678-682.
27. Staschke K & Colacino J (1994) Priming of duck hepatitis B virus reverse transcription in vitro: premature termination of primer DNA induced by the 5′-triphosphate of fialuridine. Journal of Virology 68:8265-8269.
28. Tsiquaye K, Slomka M & Maung M (1994) Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo. Journal of Medical Virology 42:306-310.
29. Tsiquaye K, Sutton D, Maung M & Boyd M (1996) Antiviral activities and pharmacokinetics of penciclovir and famciclovir in Pekin ducks chronically infected with duck hepatitis B virus. Antiviral Chemistry & Chemotherapy 7:153-159.
30. Ueda K, Tsurimoto T, Nagatha T, Chisaka O & Matsubara K (1989) An in vitro system for screening anti-hepatitis B virus drugs. Virology 169:213-216.
31. Vere Hodge R & Perkins R (1989) Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells. Antimicrobial Agents and Chemotherapy 33:223-229.
32. Wang G-H, Zoulim F, Leber E, Kitson J & Seeger C (1994) The role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses. Journal of Virology 68:8437-8442.
33. Wang G-H & Seeger C (1992) The reverse transcriptase of hepatitis B virus acts a protein primer for viral DNA synthesis. Cell 71:633-670.
34. Wang G-H & Seeger C (1993) A novel mechanism for reverse transcription in hepatitis B viruses. Journal of Virology 67:6507-6512.
35. Zoulim F, Dannaoui E, Borel C, Hantz O, Lin T, Liu S, Trépo C & Cheng YC (1996) 2′,3′-dideoxy-β-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo. Antimicrobial Agents and Chemotherapy 40:448-453.
36. Zoulim F & Seeger C (1994) Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. Journal of Virology 68:6-13.
37. Zoulim F & Trépo C (1994) Nucleoside analogues in the treatment of chronic viral hepatitis. Efficiency and complications. Journal of Hepatology 21:142-144.
38. Zoulim F, Wang G & Seeger C (1994) Methods for the purification of enzymatically active reverse transcriptase of duck hepatitis B virus. In: Viral hepatitis and liver disease. Proceedings of the international symposium on viral hepatitis and liver disease. Tokyo, May 10-14, 1993. Nishioka, K., Suzuki, H., Mishito, S. and Oda, T. (eds). Tokyo: Springer-Verlag, pp. 97-100.